About Recombinetics

Recombinetics is a global leader in proprietary gene repair and gene-editing technology. Our breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing technologies has resulted in breakthroughs in the regenerative medicine, disease research and animal agriculture.

Led by a team of expert geneticists, genome engineers, and reproductive physiologists, the company is headquartered in St. Paul, Minnesota.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology Research
location icon
Phone number
(612) 727-2000
location icon
Headquarter
3388 Mike Collins Dr,Eagan,Minnesota,US
description icon
Founded
2008
description icon
Keywords
Agriculture, Genetics, Aquaculture, Disease Models, Genetic Engineering, Regenerative Medicine, Biomedicine, Gene Editing, Genome Editing, Precision Breeding, Pre-Clinical Research

Recombinetics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Recombinetics

Who is the CEO of Recombinetics?

Tammy Lee Stanoch is the CEO of Recombinetics. To contact Tammy Lee Stanoch email at [email protected].

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more